| Financial Year |
March 31 2023 |
| Monetary Funds |
619,299,874.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,156,970.30 |
| Accounts Receivable |
457,453,376.60 |
| Advances to Suppliers |
14,850,462.29 |
| Other Receivables |
14,744,340.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
667,602,031.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,945,760.18 |
| Total Current Assets |
1,858,110,817.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
402,211,459.06 |
| Under-construction Projects |
236,961,950.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
157,646,178.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,279,528.38 |
| Deferred Income Tax Assets |
11,291,486.06 |
| Other Non-Current Assets |
40,800,591.38 |
| Sub-Total of Non-Current Assets |
864,891,088.74 |
| Total Assets |
2,723,001,906.44 |
| Short-Term Loans |
389,182,637.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
160,421,757.31 |
| Accounts Payable |
221,181,594.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,577,021.47 |
| Taxes Payable |
8,586,658.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,122,249.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,613,500.54 |
| Other Current Liabilities |
8,619,030.34 |
| Sub-Total of Current Liabilities |
978,510,682.38 |
| Long-term Loans |
52,790,000.00 |
| Bonds Payable |
135,321,059.29 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
202,935,515.09 |
| Total Liabilities |
1,181,446,197.47 |
| Paid-In Capital(Or Share Stock) |
177,743,778.00 |
| Capital Surplus |
791,477,389.05 |
| Surplus Reserve |
63,510,047.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
469,734,072.36 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,541,555,708.97 |
| Owner's Equity（Stockholder's Equity） |
1,541,555,708.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,723,001,906.44 |
